Annual report pursuant to Section 13 and 15(d)

Note 13 - Related Party Transactions

Note 13 - Related Party Transactions
12 Months Ended
Dec. 31, 2020
Notes to Financial Statements  
Related Party Transactions Disclosure [Text Block]
Related party transactions:
The Company uses Moores Cancer Center at the University of California San Diego (UCSD) to provide pharmacology lab services to the Company. Dr. Stephen Howell is a member of our Scientific Advisory Board and former Acting Chief Medical Officer of Aptose up to
January 1, 2020
and is also a Professor of Medicine at UCSD and oversees the laboratory work. The work is completed under the terms of research services agreements executed in
March 2015
and has been extended annually. These transactions are in the normal course of business and are measured at the amount of consideration established and agreed to by the related parties.
During the comparative year ended
December 31, 2019,
while Dr. Howell was Acting Chief Medical Officer, the Company recorded
thousand in research and development expenses related to the agreement.